Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Structure ; 31(7): 884-890.e2, 2023 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-37267945

RESUMEN

Ubiquitin phosphorylation at Ser65 increases the population of a rare C-terminally retracted (CR) conformation. Transition between the Major and CR ubiquitin conformations is critical for promoting mitochondrial degradation. The mechanisms by which the Major and CR conformations of Ser65-phosphorylated (pSer65) ubiquitin interconvert, however, remain unresolved. Here, we perform all-atom molecular dynamics simulations using the string method with swarms of trajectories to calculate the lowest free-energy path between these two conformers. Our analysis reveals the existence of a Bent intermediate in which the C-terminal residues of the ß5 strand shift to resemble the CR conformation, while pSer65 retains contacts resembling the Major conformation. This stable intermediate was reproduced in well-tempered metadynamics calculations but was less stable for a Gln2Ala mutant that disrupts contacts with pSer65. Lastly, dynamical network modeling reveals that the transition from the Major to CR conformations involves a decoupling of residues near pSer65 from the adjacent ß1 strand.


Asunto(s)
Simulación de Dinámica Molecular , Ubiquitina , Fosforilación , Ubiquitina/metabolismo , Conformación Molecular , Ubiquitina-Proteína Ligasas/química , Conformación Proteica
2.
Structure ; 28(10): 1168-1178.e2, 2020 10 06.
Artículo en Inglés | MEDLINE | ID: mdl-32735769

RESUMEN

Despite their classification as ionotropic glutamate receptors, GluD receptors are not functional ligand-gated ion channels and do not bind glutamate. GluD2 receptors bind D-serine and coordinate transsynaptic complexes that regulate synaptic plasticity. Instead of opening the ion channel pore, mechanical tension produced from closure of GluD2 ligand-binding domains (LBDs) drives conformational rearrangements for non-ionotropic signaling. We report computed conformational free energy landscapes for the GluD2 LBD in apo and D-serine-bound states. Unexpectedly, the conformational free energy associated with GluD2 LBD closure upon D-serine binding is greater than that for AMPA, NMDA, and kainate receptor LBDs upon agonist binding. This excludes insufficient force generation as an explanation for lack of ion channel activity in GluD2 receptors and suggests that non-ionotropic conformational rearrangements do more work than pore opening. We also report free energy landscapes for GluD2 LBD harboring a neurodegenerative mutation and demonstrate selective stabilization of closed conformations in the apo state.


Asunto(s)
Receptores de Glutamato/química , Receptores de Glutamato/metabolismo , Serina/metabolismo , Sitios de Unión , Ligandos , Simulación de Dinámica Molecular , Mutación , Dominios Proteicos , Receptores de Glutamato/genética , Serina/química , Termodinámica
3.
Structure ; 27(1): 189-195.e2, 2019 01 02.
Artículo en Inglés | MEDLINE | ID: mdl-30482727

RESUMEN

The kainate family of ionotropic glutamate receptors (iGluRs) mediates pre- and postsynaptic neurotransmission. Previously computed conformational potentials of mean force (PMFs) for iGluR ligand-binding domains (LBDs) revealed subtype-dependent conformational differences between α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartic acid (NMDA) iGluR subfamilies. Here we report PMFs for the kainate receptor GluK2 in apo and glutamate-bound states. Apo and glutamate-bound GluK2 LBDs preferentially access closed-cleft conformations. Apo GluK2 exhibits a surprisingly high degree of conformational flexibility, accessing open and closed states. Comparing across iGluR subtypes, these results are similar to glycine-binding GluN1 and GluN3A NMDA subunits and differ from glutamate-binding GluA2 and GluN2A subunits. To test the contribution of cross-lobe interactions on closed-cleft LBD stability, we computed PMFs for two GluK2 mutants, D462A and D656S. D462A, but not D656S, weakens closed-cleft conformations of the glutamate-bound LBD. Theoretical Boltzmann-weighted small-angle X-ray scattering profiles improve agreement with experimental results compared with calculations from the LBD crystal structure alone.


Asunto(s)
Simulación de Dinámica Molecular , Receptores de Ácido Kaínico/química , Animales , Sitios de Unión , Glutamatos/química , Glutamatos/metabolismo , Simulación del Acoplamiento Molecular , Unión Proteica , Receptores de Ácido Kaínico/metabolismo , Receptor de Ácido Kaínico GluK2
4.
Physiol Behav ; 103(3-4): 376-83, 2011 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-21397618

RESUMEN

Bipolar disorder (BPD) is a devastating long-term disease for which a significant symptom is mania. Rodent models for mania include psychostimulant-induced hyperactivity and single gene alterations, such as in the Clock or DAT genes, but there is still a pressing need for additional models. Recently, our lab isolated a line of mice, termed Madison (MSN), that exhibit behavioral characteristics that may be analogous to symptoms of mania. In this study we quantified possible traits for mania and tested the response to common anti-BPD drugs in altering the behavioral profiles observed in this strain. Relative to other mouse lines, MSN mice showed significant elevations of in-cage hyperactivity levels, significant decreases in daytime sleep, and significant increases in time swimming in the forced swim test. In terms of sexual behavior, the MSN mice showed significantly higher number of mounts and a trend toward higher time mounting. In separate studies, olanzapine and lithium (or respective controls) were administered to MSN mice for at least 2weeks and response to treatments was evaluated. Olanzapine (1mg/kg/day) significantly decreased in-cage hyperactivity and significantly increased time sleeping. Lithium (0.2-0.4% in food) significantly decreased in-cage hyperactivity. Given the behavioral phenotypes and the response to anti-BPD treatments, we propose that MSN mice may provide a possible new model for understanding the neural and genetic basis of phenotypes related to mania and for developing pharmaceutical treatments.


Asunto(s)
Antimaníacos/uso terapéutico , Benzodiazepinas/uso terapéutico , Trastorno Bipolar/tratamiento farmacológico , Trastorno Bipolar/fisiopatología , Cloruro de Litio/uso terapéutico , Animales , Conducta Animal , Peso Corporal/efectos de los fármacos , Adaptación a la Oscuridad/efectos de los fármacos , Adaptación a la Oscuridad/fisiología , Modelos Animales de Enfermedad , Conducta Exploratoria/efectos de los fármacos , Ratones , Olanzapina , Conducta Sexual Animal/efectos de los fármacos , Sueño/efectos de los fármacos , Natación/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA